e-learning
resources
Munich 2014
Tuesday, 09.09.2014
New mechanisms in the pathogenesis of asthma and other lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease
L. Vocca, A. Sala, S. Gangemi, C. Di Sano, L. Riccobono, C. Uasuf, G. Anzalone, A. Bonanno, R. P. Gagliardo, M. Profita (Palermo, Milan, Messina, Italy)
Source:
International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session:
New mechanisms in the pathogenesis of asthma and other lung diseases
Session type:
Thematic Poster Session
Number:
3876
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Vocca, A. Sala, S. Gangemi, C. Di Sano, L. Riccobono, C. Uasuf, G. Anzalone, A. Bonanno, R. P. Gagliardo, M. Profita (Palermo, Milan, Messina, Italy). Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease. Eur Respir J 2014; 44: Suppl. 58, 3876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Autoimmunity in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Airway remodeling and eosinophilic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
The U-BIOPRED severe asthma study: Immunopathological characterisation
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Alveolar macrophages phenotype in patients with asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept